Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban – an oral, direct Factor Xa inhibitor

by Rolf eBurghaus, Katrin eCoboeken, Thomas eGaub, Christoph eNiederalt, Anke eSensse, Hans-Ulrich eSiegmund, Wolfgang eWeiss, Wolfgang eMueck, Takahiko eTanigawa, Joerg eLippert
Published 2014-11-01